Blog Posts in May, 2012

Fosamax: FDA Conducts Review Confirming Long-Term Use Has No Benefit

The Food and Drug Administration (FDA) has conducted a second analysis of bisphosponates, including Fosamax. In 2004, the FDA’s first analysis linked Fosamax (alendronate) , a prescription drug ...
Continue Reading +